Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nikta Shobeiri
Observed names:
N. Shobeiri,
Shobeiri, Nikta
Institution:
Mashhad University of Medical Sciences
Observed institutions:
Mashhad University of Medical Sciences,
Shahid Beheshti University,
Shahid Beheshti University of Medical Sciences
ORCID:
0000-0001-9486-9361
Observed ORCID:
0000-0001-9486-9361
OpenAlex ID:
A5023441013
Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors
2016
·
Nikta Shobeiri
, Maryam Rashedi
, et al.
·
European Journal of Medicinal Chemistry
·
107
Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country.
2019
·
Hossein Minaei
, Mohammad Peikanpour
, et al.
·
PubMed Central
·
14
PDF
Strategic Approaches for Overcoming Peptide and Protein Drug Limitations
2025
·
Mahsa Cheshomi
, Nikta Shobeiri
, et al.
·
The Protein Journal
·
13
Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis
2024
·
Behzad Fatemi
, Neda Yaghoubi
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
4
Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
2023
·
Mahdieh Fathi
, Najmeh Moradi
, et al.
·
BMC Pulmonary Medicine
·
3
PDF
Economic Burden of Diseases Caused by Air Pollution in Iran: A Cross‐Sectional Study
2025
·
Nikta Shobeiri
, Amin Adel
, et al.
·
Health Science Reports
·
2
PDF
Association between vitamin D deficiency and general and abdominal obesity in older adults: insights from baseline data of the Birjand Longitudinal Aging Study (BLAS)
2025
·
Mehdi Varmaghani
, Amirmohammad Tajik
, et al.
·
Journal of Diabetes & Metabolic Disorders
·
1
Cost Analysis of Diagnosis and Treatment of Venous Thromboembolism in Total Knee Replacement Patients
2025
·
Hadi Alizadeh Siuki
, Nikta Shobeiri
, et al.
·
Health Technology Assessment in Action
How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
2022
·
Nikta Shobeiri
, Farzad Peiravian
, et al.
·
Iranian journal of pharmaceutical research
PDF
PCN23 Cost-Effectiveness Analysis of Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride, and paclitaxel As Second-LINE Chemotherapy in the Treatment of Platinum-Resistant Ovarian Cancer in Iran
2020
·
N. Shobeiri
·
Value in Health Regional Issues
Pcn212 Economic Evaluation of Topotecan in Comparison With Pegylated Liposomal Doxorubicin in the Treatment of Recurrent Ovarian Cancer in Iran
2019
·
S. Sheikhi
, S. Taheri
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
12
Citation count:
144
H-index:
4
I10-index:
3
Year
Topic
Type